DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

India Glycols Limited — Price movement

NSE 1 hr ago·9 Oct 2026, 10:27 am

India Glycols

India Glycols Limited has seen significant movement in its stock price, prompting the stock exchange to seek clarification from the company. The exchange wrote to the firm to ensure that all relevant information is available to the market. In response, India Glycols has submitted its explanation to the exchange.

This development matters to investors as it highlights the importance of transparency during periods of high volatility. The exchange's intervention is a standard procedure to protect the interests of shareholders by ensuring that any material information is disclosed promptly. The market will be closely watching for the specific details of the company's response.